Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Allakos Inc. (ALLK)  
$1.06 0.01 (0.93%) as of 4:30 Mon 4/22


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 85,210,000
Market Cap: 90.32(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.02 - $5.55
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Allakos is a clinical stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases. Co.'s antibodies are lirentelimab (AK002) and AK006. Co. is developing lirentelimab for the treatment of eosinophilic gastritis/eosinophilic duodenitis, eosinophilic esophagitis, atopic dermatitis, chronic spontaneous urticaria and potentially additional indications. AK006 targets Siglec-6, an inhibitory receptor selectively expressed on various cells. AK006 appears to have the potential to provide various cell inhibition than lirentelimab.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 4,459,000
Total Buy Value $0 $0 $0 $22,384,180
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 135
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walker Paul Edward Director   –       •      –    2022-09-21 4 B $5.02 $19,999,680 I/I 3,984,000 3,386,400 2.1 37%     
   Janney Daniel Director   –       •       •   2022-09-21 4 B $5.02 $2,384,500 I/I 475,000 2,546,147 2.25 37%     
   Fitzgerald Margaret Nell General Counsel and Secretary   •       –      –    2022-09-02 4 D $4.54 $1,521 D/D (335) 153,128     -
   Tomasi Adam President and COO   •       –      –    2022-09-02 4 D $4.54 $24,375 D/D (5,369) 558,520     -
   Alexander Robert Chief Executive Officer   •       •      –    2022-09-02 4 D $4.54 $37,755 D/D (8,316) 770,271     -
   Radford Harlan Baird Chief Financial Officer   •       –      –    2022-09-02 4 D $4.54 $2,656 D/D (585) 276,104     -
   Paterson Craig A. Chief Medical Officer   •       –      –    2022-09-02 4 D $4.54 $5,126 D/D (1,129) 274,647     -
   Alexander Robert Chief Executive Officer   •       •      –    2022-06-02 4 D $2.75 $22,231 D/D (8,084) 778,587     -
   Fitzgerald Margaret Nell General Counsel and Secretary   •       –      –    2022-06-02 4 D $2.75 $875 D/D (318) 150,463     -
   Tomasi Adam President and COO   •       –      –    2022-06-02 4 D $2.75 $14,352 D/D (5,219) 563,889     -
   Radford Harlan Baird Chief Financial Officer   •       –      –    2022-06-02 4 D $2.75 $6,254 D/D (2,274) 276,689     -
   Paterson Craig A. Chief Medical Officer   •       –      –    2022-06-02 4 D $2.75 $622 D/D (226) 275,776     -
   Paterson Craig A. Chief Medical OfficerOfficer   •       –      –    2022-04-28 3 IO $0.00 $0 D/D 0 276,002 20%     
   Fitzgerald Margaret Nell General Counsel and SecretaryO   •       –      –    2022-04-19 3 IO $0.00 $0 D/D 0 93,144 -17%     
   Fitzgerald Margaret Nell General Counsel and Secretary   •       –      –    2022-04-19 4 A $0.00 $0 D/D 57,637 150,781     -
   Tomasi Adam President and COO   •       –      –    2022-03-02 4 D $5.38 $30,031 D/D (5,582) 569,108     -
   Alexander Robert Chief Executive Officer   •       •      –    2022-03-02 4 D $5.38 $44,197 D/D (8,215) 786,671     -
   Asbury Mark CLOGC and Secretary   •       –      –    2022-03-02 4 D $5.38 $9,038 D/D (1,680) 226,935     -
   Radford Harlan Baird Chief Financial Officer   •       –      –    2022-02-25 4 A $0.00 $0 D/D 237,608 278,963     -
   Alexander Robert Chief Executive Officer   •       •      –    2022-02-25 4 A $0.00 $0 D/D 529,323 794,886     -
   Asbury Mark CLOGC and Secretary   •       –      –    2022-02-25 4 A $0.00 $0 D/D 140,490 228,615     -
   Tomasi Adam President and COO   •       –      –    2022-02-25 4 A $0.00 $0 D/D 344,060 574,690     -
   Alexander Robert Chief Executive Officer   •       •      –    2021-12-02 4 D $78.69 $1,592,764 D/D (20,241) 265,250     -
   Tomasi Adam President and COO   •       –      –    2021-12-02 4 D $78.69 $1,028,242 D/D (13,067) 230,317     -
   Asbury Mark CLOGC and Secretary   •       –      –    2021-12-01 4 A $0.00 $0 D/D 26,003 87,813     -
  135 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us